MARCOS
GONZÁLEZ DÍAZ
Ikertzailea 1993-2023 tartean
University of California Los Angeles
Los Ángeles, Estados UnidosUniversity of California Los Angeles-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477